Patents by Inventor Lonna Munro

Lonna Munro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TO L-TYPE VOLTAGE GATED CHANNELS AND RELATED METHODS
    Publication number: 20230203154
    Abstract: Provided are antibodies, and antigen-binding fragments thereof, which specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage gated calcium channel, and related compositions, kits, and methods of use thereof, for instance, administration to a subject in need thereof to modify an immune response, for example, in the treatment of cancer.
    Type: Application
    Filed: September 16, 2022
    Publication date: June 29, 2023
    Inventors: Wilfred Arthur Jefferies, Kyung Bok Choi, Shawna Rose Stanwood, Franz Fenninger, Brett Alexander Eyford, Lonna Munro, Cheryl Gurine Pfeifer, Reinhard Gabathuler
  • Antibodies to L-type voltage gated channels and related methods
    Patent number: 11492400
    Abstract: Provided are antibodies, and antigen-binding fragments thereof, which specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage gated calcium channel, and related compositions, kits, and methods of use thereof, for instance, administration to a subject in need thereof to modify an immune response, for example, in the treatment of cancer.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: November 8, 2022
    Assignee: The University of British Columbia
    Inventors: Wilfred Arthur Jefferies, Kyung Bok Choi, Shawna Rose Stanwood, Franz Fenninger, Brett Alexander Eyford, Lonna Munro, Cheryl Gurine Pfeifer, Reinhard Gabathuler
  • A METHOD OF IMMUNE MODULATION BY MODULATING ABCF1
    Publication number: 20220125876
    Abstract: The present invention relates to methods of immune modulation. In particular, the present invention relates to regulation of inflammation and immune responses by modulation of ABCF1. Modulation of ABCF1 may be useful in the treatment of sepsis, autoimmune diseases, cancer or infections.
    Type: Application
    Filed: February 14, 2020
    Publication date: April 28, 2022
    Applicant: Pacific Myco Biosciences, Ltd.
    Inventors: Wilfred JEFFERIES, Hitesh ARORA, Sara WILCOX, Lonna MUNRO, Cheryl PFEIFER
  • ANTIBODIES TO L-TYPE VOLTAGE GATED CHANNELS AND RELATED METHODS
    Publication number: 20200385458
    Abstract: Provided are antibodies, and antigen-binding fragments thereof, which specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage gated calcium channel, and related compositions, kits, and methods of use thereof, for instance, administration to a subject in need thereof to modify an immune response, for example, in the treatment of cancer.
    Type: Application
    Filed: January 24, 2020
    Publication date: December 10, 2020
    Inventors: Wilfred Arthur Jefferies, Kyung Bok Choi, Shawna Rose Stanwood, Franz Fenninger, Brett Alexander Eyford, Lonna Munro, Cheryl Gurine Pfeifer, Reinhard Gabathuler
  • ANTIBODIES TO L-TYPE VOLTAGE GATED CHANNELS AND RELATED METHODS
    Publication number: 20180022803
    Abstract: Provided are antibodies, and antigen-binding fragments thereof, which specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage gated calcium channel, and related compositions, kits, and methods of use thereof, for instance, administration to a subject in need thereof to modify an immune response, for example, in the treatment of cancer.
    Type: Application
    Filed: February 16, 2016
    Publication date: January 25, 2018
    Inventors: Wilfred Arthur Jefferies, Kyung Bok Choi, Shawna Rose Stanwood, Franz Fenninger, Brett Alexander Eyford, Lonna Munro, Cheryl Gurine Pfeifer, Reinhard Gabathuler